No. | Group | Gender | Initial manifestation/age | Major clinical signs | Age at neuropsychiatric onset | Age at diagnosis | Defected gene | Genotypes | Location | Predicted amino acid changes | ALT (IU/L) | AST (IU/L) | bone marrow biopsy | 7-KC (ng/mL) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | early infantile | F | frequent falls, 1y | delayed motor/neuron development, splenomegaly | 1 y | 4 y | NPC1 | c.1501G>T + c.1800delC | E9 + E12 | p.D501Y + p.I601FfsX13 | 16 | 97 | foam cells | 391.6 |
2 |  | F | splenomegaly, 6 m | splenomegaly, global developmental delay, diarrhea, seizure at 7 y, cerebral atrophy on brain imaging | 1 y | 8 y | NPC2 | c.3G>C + IVS2 + 5G > A | E1 + IVS2 | p.M1I + IVS2 + 5G > A | 4 | 66 | foam cells | 220.8 |
3 |  | M | splenomegaly, 1y | splenomegaly, frequent falls when started independent walking at 1.5 y, congenital cleft lip and palate, language delay, gelastic cataplexy from 2.5 y, positive family history | 1.5 y | 3 y | NPC1 | c.416_417insC + c.1832A>G | E3 + E12 | p.N140KfsX30 + p.D611G | 10 | 72 | foam cells | 602.7 |
4 |  | M | prolonged jaundice,15 ds after birth | prolonged jaundice, hepatosplenomegaly, frequent falls when started independent walking at 1 y, slower intelligence progression, psychomotor regression and gelastic cataplexy from 3 y | 1 y | 5 y 10 m | NPC1 | c.2177G>C + c.3734_3735delCT | E14 + E24 | p.R726T + p.P1245RfsX12 | 149* | 301* | foam cells | 445.8 |
5 |  | M | delayed independent walk, 1y8m | slow motor development, hepatosplemegaly, psychomotor regression at 2 y | 1 y 8 m | 2 y 2 m | NPC1 | c.2230_2231delGT + c.3734_3735delCT | E14 + E24 | p.V744SfsX27 + p.P1245RfsX12 | 27 | 83 | foam cells | 417.5 |
6 |  | F | frequent falls,1y3m | frequent falls when walking, gelastic cataplexy, motor regression at 3 y, splenomegaly | 1 y 3 m | 7y | NPC1 | c.1553G>A + c.2795dupA | E9 + E18 | p.R518Q + p.Y932X | 15 | 75 | foam cells | 161.7 |
7 |  | M | frequent falls, 1y8m | frequent falls when walking, gelastic cataplexy, splenomegaly, younger brother of patient 6 | 1 y 8 m | 3y7m | NPC1 | c.1553G>A + c.2795dupA | E9 + E18 | p.R518Q + p.Y932X | N.D | N.D | N.D | 101.6 |
8 | late infantile | M | hepatosplenomegaly, 1y8m | hepatosplemegaly, thrombocytopenia, psychomotor regression at 2.5 y | 2 y 6 m | 1 y 8 m | NPC1 | c.2302_2303insG + c.2912-3C>G | E15 + IVS19 | p.V768GfsX4 + c.2912-3C > G | 24 | 75 | foam cells | 150.6 |
9 | juvenile | M | ataxia, 8ys | ataxia, progressively loss of memory, loss of language at 9 ys, seizure from 12 y, thrombocytopenia without splenomegaly | 8 y | 13 y | NPC1 | c. 1502A>T + c. 3634G>T | E9 + E24 | p.D501V + p.V1212L | 10 | 59 | N.D | 108 |
10 | adult | M | visual and auditory hallucination, 16 ys | schizophrenia-like psychosis, splenomegaly deteced by abdominal ultrasound, intestinal constipation | 16 y | 20 y | NPC1 | c.2366G>A + c.2972_2973delAG | E15 + E20 | p.R789H + p.Q991RfsX15 | 34.7 | 39.6 | N.D | 32 |
11 | unknown | M | delayed jaundice regression, 1 m | delayed jaundice regression, increasing splenomegaly, mild hepatomegaly | N.A | 14 m | NPC1 | c.2054T>C + c.2128C>T | E13 + E13 | p.I685T + p.Q710X | 59* | 145* | foam cells | 456.3 |
12 |  | F | splenomegaly, 3y3m | isolated splenomegaly | N.A | 3y5m | NPC1 | c.1030del>T + c.2861C>T | E8 + E19 | p.S344KfsX105 + p.S954L | N.D | N.D | N.D | 232.3 |